2nd Vienna Multidisciplinary Symposium on Antibody-Mediated Rejection after Lung Transplantation
21 March to 22, 2024
Over the last years, antibody-mediated rejection has increasingly gained importance due to its high morbidity and mortality. Exact pathogenic process is largely unknown. The major contribution to our current understanding and therapeutic strategy derives from different disciplines. Therefore, a multidisciplinary approach is of paramount importance to tackle the several questions which remain unresolved.
The Vienna Multidisciplinary Symposium on humoral immunity after lung transplantation offers a whole overview on this topic for the first time. Top-leading scientists and transplant physicians are invited to elaborate different area and perspectives of this threatening complication after lung transplantation. Finally, inclusion of a multidisciplinary faculty allows a holistic approach for interesting discussions.